Page last updated: 2024-11-04

sulfasalazine and Bilateral Deafness

sulfasalazine has been researched along with Bilateral Deafness in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Savastano, M1
Marioni, G1
Bernini, G1
Punzi, L1

Reviews

1 review available for sulfasalazine and Bilateral Deafness

ArticleYear
Tinnitus and bilateral sensorineural hearing loss: ankylosing spondylitis or a side-effect of sulphasalazine treatment?
    Acta oto-laryngologica, 2005, Volume: 125, Issue:6

    Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Audiometry, Pure-Tone; Auditory Threshold; Follow-Up

2005